The calculation of diluted net loss per share gives effect to common stock equivalents; however, potential
common shares are excluded if their effect is anti-dilutive.
Particulars | |
June 30, 2024 | | |
June 30, 2023 | |
Basic and diluted EPS* | |
| | |
| |
Numerator | |
| | |
| |
Net income/(loss) | |
| (1,283 | ) | |
| (189 | ) |
Net Income attributable to common stockholders | |
| (1,283 | ) | |
| (189 | ) |
Denominator | |
| | | |
| | |
Weighted average common shares outstanding | |
| 199,175,526 | | |
| 6,043,236 | |
Number of shares used for basic EPS computation | |
| | | |
| | |
Basic EPS | |
| (0.01 | ) | |
| (0.03 | ) |
Number of shares used for diluted EPS computation* | |
| 615,175,526 | | |
| 6,043,236 | |
Diluted EPS | |
| (0.00 | ) | |
| (0.03 | ) |
Includes 26,552 issued warrants as of June 30, 2023. Includes 26,552 issued warrants 416,000 Series B stocks converting
into 416,000,000 common stocks as of June 30, 2024.
|